April 03, 2025

FDA Reaches Decision on Reproxalap

The FDA’s Complete Response Letter recommends an additional trial that focuses on DED symptoms.

Conexiant

March 06, 2025

FDA Approves First Treatment for MacTel

Neurotech’s ocular insert Encelto aims to slow vision loss in patients with this degenerative retinal disease.

Retinal Physician

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters

March 01, 2024

EDITOR'S PERSPECTIVE

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

August 15, 2024

Major Medicare Drug Price Cuts Announced

Biden administration secures up to 79% in reductions on top-selling medications.

Reuters

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters